Clonal diversity in KRAS mutant colorectal adenocarcinoma under treatment: Monitoring of cfDNA using reverse hybridization and DNA sequencing platforms

Biological heterogeneity is a key feature of malignancies that significantly contributes to disease progression and therapy resistance. Residual/relapsed tumor foci may represent genetically divergent subclones, which remain uncovered as repeated and multiple tumor sampling is usually limited. The a...

Full description

Bibliographic Details
Main Authors: Emese Sarolta Bádon, Attila Mokánszki, Anikó Mónus, Csilla András, Gábor Méhes
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:Molecular and Cellular Probes
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0890850822001025

Similar Items